title: Prostate cancer: Cabazitaxel-a key therapeutic option in prostate cancer.
authors.affiliation: The Institute of Cancer Research, 123 Old Brompton Road, London SW7 3RP, UK.
authors.forename: Anuradha
authors.initials: A
authors.lastname: Jayaram
authors.affiliation: The Institute of Cancer Research, 123 Old Brompton Road, London SW7 3RP, UK.
authors.forename: Gerhardt
authors.initials: G
authors.lastname: Attard
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor; D001859:Bone Neoplasms / Q000556:secondary; D029742:Caenorhabditis elegans Proteins; D006305:Health Status Indicators; D006801:Humans; D008297:Male; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy* / Q000473:pathology; D011788:Quality of Life; D043823:Taxoids / Q000627:therapeutic use*; D044763:Ubiquitin-Conjugating Enzymes
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D029742:Caenorhabditis elegans Proteins; D043823:Taxoids; C559057:Uev-1 protein, C elegans; C552428:cabazitaxel; D044763:Ubiquitin-Conjugating Enzymes